Overview

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

Status:
COMPLETED

Trial end date:
2025-02-03

Target enrollment:

Participant gender:

Summary

This study is a randomized, open-label, single arm, multi-dose, crossover study to evaluate drug-drug interaction and safety after co-administration of D352 and D794 in healthy adult volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

1-stearoyl-d35-2-docosahexaenoyl-sn-glycero-3-phosphocholine